These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 3759916

  • 1. The dexamethasone suppression test in bulimia before and after successful treatment with desipramine.
    Hughes PL, Wells LA, Cunningham CJ.
    J Clin Psychiatry; 1986 Oct; 47(10):515-7. PubMed ID: 3759916
    [Abstract] [Full Text] [Related]

  • 2. The dexamethasone suppression test in patients with bulimia.
    Mitchell JE, Pyle RL, Hatsukami D, Boutacoff LI.
    J Clin Psychiatry; 1984 Dec; 45(12):508-11. PubMed ID: 6594328
    [Abstract] [Full Text] [Related]

  • 3. The dexamethasone suppression test in bulimia: nonsuppression associated with depression and suboptimal weight.
    Perez EL, Blouin J, Blouin A.
    J Clin Psychiatry; 1988 Mar; 49(3):94-6. PubMed ID: 3346203
    [Abstract] [Full Text] [Related]

  • 4. Two diagnostic correlates of dexamethasone nonsuppression in normal weight bulimia.
    Blinder BJ, Chaitin BF, Hagman J.
    Hillside J Clin Psychiatry; 1987 Mar; 9(2):211-6. PubMed ID: 3428880
    [Abstract] [Full Text] [Related]

  • 5. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.
    Albala AA, Greden JF, Tarika J, Carroll BJ.
    Biol Psychiatry; 1981 Jun; 16(6):551-60. PubMed ID: 7260217
    [Abstract] [Full Text] [Related]

  • 6. Dexamethasone suppression in depressed elderly outpatients.
    Allen RE, Pitts FN.
    J Clin Psychiatry; 1984 Sep; 45(9):397-8. PubMed ID: 6469926
    [Abstract] [Full Text] [Related]

  • 7. The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment.
    Escobar JI, Halaris A, Baxter L, Schwarcz G, Thompson M, Hurwicz ML, Hill M, Young M, Daugherty K, Clemens A.
    Psychopharmacol Bull; 1985 Sep; 21(1):77-80. PubMed ID: 3920706
    [No Abstract] [Full Text] [Related]

  • 8. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
    Kraus RP, Remick RA.
    J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
    [Abstract] [Full Text] [Related]

  • 9. d-Amphetamine response and dexamethasone suppression test as predictors of treatment outcome in unipolar depression.
    Ettigi PG, Hayes PE, Narasimhachari N, Hamer RM, Goldberg S, Secord GJ.
    Biol Psychiatry; 1983 Apr; 18(4):499-504. PubMed ID: 6860724
    [No Abstract] [Full Text] [Related]

  • 10. Dexamethasone suppression test status does not predict differential response to nortriptyline versus amitriptyline.
    Rush AJ, Weissenburger J, Vasavada N, Orsulak PJ, Fairchild CJ.
    J Clin Psychopharmacol; 1988 Dec; 8(6):421-5. PubMed ID: 3069882
    [Abstract] [Full Text] [Related]

  • 11. Dexamethasone suppression test in primary depression: significance of family history and psychosis.
    Rudorfer MV, Hwu HG, Clayton PJ.
    Biol Psychiatry; 1982 Jan; 17(1):41-8. PubMed ID: 7059638
    [Abstract] [Full Text] [Related]

  • 12. Neuroendocrine dysfunction and response to tricyclic antidepressants.
    Kirstein L.
    J Clin Psychiatry; 1984 Sep; 45(9):385-6. PubMed ID: 6432772
    [Abstract] [Full Text] [Related]

  • 13. [Value of the dexamethasone suppression test in anorexia nervosa].
    Herpertz-Dahlmann B, Remschmidt H.
    Monatsschr Kinderheilkd; 1987 Nov; 135(11):758-62. PubMed ID: 3431557
    [Abstract] [Full Text] [Related]

  • 14. Cortisol responses on the dexamethasone suppression test among women with Bulimia-spectrum eating disorders: associations with clinical symptoms.
    Bruce KR, Steiger H, Israël M, Groleau P, Ng Ying Kin NM, Ouellette AS, Sycz L, Badawi G.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug 07; 38(2):241-6. PubMed ID: 22575215
    [Abstract] [Full Text] [Related]

  • 15. [The prognostic value of the dexamethasone suppression test for the course of anorexia nervosa--comparison with depressive diseases].
    Herpertz-Dahlmann B, Remschmidt H.
    Z Kinder Jugendpsychiatr; 1990 Mar 07; 18(1):5-11. PubMed ID: 2336880
    [Abstract] [Full Text] [Related]

  • 16. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD.
    Biol Psychiatry; 1984 Mar 07; 19(3):305-18. PubMed ID: 6426529
    [Abstract] [Full Text] [Related]

  • 17. The dexamethasone suppression test in schizophrenia.
    Sawyer J, Jeffries JJ.
    J Clin Psychiatry; 1984 Sep 07; 45(9):399-402. PubMed ID: 6469927
    [Abstract] [Full Text] [Related]

  • 18. Neuroendocrine abnormalities in affective disorders.
    Extein I, Pottash AL, Gold MS.
    Encephale; 1982 Sep 07; 8(2):203-11. PubMed ID: 6809445
    [Abstract] [Full Text] [Related]

  • 19. The dexamethasone suppression test in depressed patients: clinical and biochemical aspects.
    Holsboer F.
    J Steroid Biochem; 1983 Jul 07; 19(1A):251-7. PubMed ID: 6887861
    [Abstract] [Full Text] [Related]

  • 20. The dexamethasone suppression test in patients with alcoholism.
    Kroll P, Palmer C, Greden JF.
    Biol Psychiatry; 1983 Apr 07; 18(4):441-50. PubMed ID: 6860720
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.